Clinical Trial Update: Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the immune response when the oral typhoid vaccine Vivotif and the cholera vaccine Dukoral are given together, assessing potential imm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera
• Typhoid Fever

Drugs mentioned

• Dukoral (Cholera vaccine (inactivated whole-cell with recombinant B subunit))
• Vivotif (Ty21a live attenuated typhoid vaccine)

Snippet

Sponsor: Helsinki University Central Hospital | Conditions: Vaccine-Preventable Diseases, Typhoid Fever | Phase 4 | Status: COMPLETED